Facebook-f Twitter Linkedin-in Welcome to the 121th FOAMed Quiz.   Question 1 In addition to Toculizumab and Dexamethasone, the REGN monoclonal antibodies combination (Casirivimab and Imdevimab) have shown to be beneficial in patients with COVID-19 according to this part of the RECOVERY trial. However, the Casirivimab and Imdevimab combination was only associated with reduced mortality, … Continue reading Quiz 121, July 2nd , 2021